Back to Search
Start Over
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine
- Source :
- Gastroenterology, 164, 2, pp. 300-303.e3, Gastroenterology, 164, 300-303.e3
- Publication Year :
- 2023
-
Abstract
- Contains fulltext : 291656.pdf (Publisher’s version ) (Open Access)
Details
- ISSN :
- 00165085
- Database :
- OpenAIRE
- Journal :
- Gastroenterology, 164, 2, pp. 300-303.e3, Gastroenterology, 164, 300-303.e3
- Accession number :
- edsair.doi.dedup.....157731aa6412cb6ad216dbf0adf0dca5